Genmab — Marts 2021

Bulder

Lignede det ikke en stærk slutspurt i us? NBI fik trukket sig selv ved håret op af den røde sump.

Solsen

Jo ingen nervøsitet op til weekenden er vel et godt tegn.

Bulder

Det så ellers dystert ud lige indtil en time før luk.

Havneholmen

U.S. Food and Drug Administration Approves Bristol Myers Squibb’s and bluebird bio’s Abecma (idecabtagene vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed or Refractory Multiple Myeloma

Solsen

Det lignede den usynlige hånd den sidste time

Helge_LarsenPI-redaktør

God morgen.

Helge_LarsenPI-redaktør

Bluebird: https://www.proinvestor.com/boards/92007#postdiv92357

ungeee

@5.38 Hvis man ikke er opdateret...hvad betyder det for GEN?

GeorgeBest

Ikke noget særligt, Darzalex bruges i de føtste linier af behandlingen, CAR-T kommer først i betagtning, når de gængse behandlinsformer ikke mere virker.

Sukkeralf

Over tid måske mere en konkurrent til Janssens DuoBody Teclistamab, som Genmab også har andel i. Eller måske til GSKs BCMA ADC Blenrep og andre BCMA kandidater der følger trop

E_L

i saw a documentary a few weeks ago from the BBC, where they followed 2 patients receiving CAR-T. It was just awful to see how sick they got when they received it... I am not sure how many patients would be able to go through this...

E_L

These 2 patients relapsed, and then decided not to take a last dose, but to have a few last months of quality life; at the end they showed their funerals...

E_L

Offcourse, they also showed pictures of patients that were still in remission. But I have to say, i was a bit shocked to see what cytokine release syndrome and neurotoxicity really is, it is 1 thing to read about it, but seeing it made it real...